Literature DB >> 17419939

Structural biology of the tumor suppressor p53 and cancer-associated mutants.

Andreas C Joerger1, Alan R Fersht.   

Abstract

The tumor suppressor protein p53 is a transcription factor that plays a key role in the prevention of cancer development. In response to oncogenic or other stresses, the p53 protein is activated and regulates the expression of a variety of target genes, resulting in cell cycle arrest, senescence, or apoptosis. Mutation of the p53 gene is the most common genetic alteration in human cancer, affecting more than 50% of human tumors. Most of these mutations inactivate the DNA-binding domain of the protein. In this chapter, we describe the structure of the wild-type p53 protein and present structural and functional data that provide the molecular basis for understanding the effects of common cancer mutations. Further, we assess novel therapeutic strategies that aim to rescue the function of p53 cancer mutants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419939     DOI: 10.1016/S0065-230X(06)97001-8

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  37 in total

Review 1.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

2.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

Review 3.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 4.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  One-Dimensional Search Dynamics of Tumor Suppressor p53 Regulated by a Disordered C-Terminal Domain.

Authors:  Agato Murata; Yuji Itoh; Eriko Mano; Saori Kanbayashi; Chihiro Igarashi; Hiroto Takahashi; Satoshi Takahashi; Kiyoto Kamagata
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

Review 6.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

7.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept.

Authors:  Vladimir N Uversky
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

9.  Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Authors:  Sebastian Kehrloesser; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Karen Heather Vousden; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

Review 10.  The protein kingdom extended: ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation.

Authors:  Konstantin K Turoverov; Irina M Kuznetsova; Vladimir N Uversky
Journal:  Prog Biophys Mol Biol       Date:  2010-01-25       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.